“In our study, Black patients with TED presented with fewer clinical exam features based on current classification guidelines, but had longer follow-up and underwent similar treatments as White ...

IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month ...

A new case report highlights a patient who presented with seizure-like symptoms but was later diagnosed with the rare lysosomal storage disorder. Fabry disease (FD) is a rare disease, but is also ...

The researchers found that, in early Lyme disease presentation, there was a higher occurrence of heart palpitations, vomiting, and photophobia among women, while sleep difficulty was greater among men ...

Presentation highlights potential for VG-3927 to treat neurodegenerative diseases associated with microglial dysfunction, like AD, due to its differentiated neuroprotective profile and ability to ...

Vision accounts for more than 80% of the information humans obtain from the outside world. The ability of the eyeballs to capture and process visual information sent onward to the brain relies ...

Real-world assessment of capecitabine and oxaliplatin (CAPOX) tolerability in patients with localized colorectal cancer undergoing curative-intent therapy: A comprehensive single institution analysis.

Input from patients with breast cancer is critical for clinicians to understand both drug resistance (reduced effectiveness of a treatment for a disease) and sensitivity (how the body reacts to a ...